Biden’s pick for patent office should defend consumers, not big business

-

- Advertisment -

What kind of rights would that mean the official overseeing patents and trademarks would be backing? Dayen has some examples. “Alcon, the largest global manufacturer of contact lenses, sued over trademark infringement to block a discount retailer, Allied Vision Group, from selling what Alcon claims are discontinued versions of its products in different packaging,” he reports. “The trademark is not about the lenses, which are FDA-approved, but the packaging; Allied Vision calls it a transparent attempt to force a discount retailer off the market so the 45 million contact lens users in the U.S. must go to Alcon for their needs.”

The packaging. Meanwhile, contact lens-wearing is yet another place we see racial disparities, with Black, and to a lesser extent, Hispanic people underrepresented among contact-wearers. You have to wonder how much that has to do with the cost, given persistent income and wealth inequality.

Pharmaceutical companies also use patents to keep forcing people to pay for their products rather than getting generics, Dayen notes: “Drug companies file multiple patents on the same product, known as ‘patent thickets,’ to extend exclusivity rights and enjoy monopoly profits, leading to overcharging consumers on the order of $315 billion in the U.S. in 2018, according to a study from economist Dean Baker.”

This issue got a burst of attention recently when Rep. Katie Porter once again broke out her whiteboard during a House hearing with pharmaceutical executives, dissecting AbbVie CEO Richard Gonzalez on his company’s expenses for things like stock buybacks and executive pay vs. research and development. Pointing to the “patent thicket” model, Porter said, “You lie to patients when you charge them twice as much for an unimproved drug and then you lie to policymakers when you tell us that R&D justifies those price increases.”

While Coons lobbies Biden to go with a defender of patent owners and longer and stronger patents, Biden is getting pressure from progressive groups to choose someone who will push back against monopolies and weigh consumer interests in decision-making. The current result is that Biden hasn’t nominated anyone to head the U.S. Patent and Trademark Office—which is exactly the right time for the rest of us to start paying attention to this issue.

Disclaimer: This article is for informational purposes only. It is not a direct offer or solicitation of an offer to buy or sell, or a recommendation or endorsement of any products, services, or companies. AllStocksNews.com does not provide investment, tax, legal, or accounting advice. Neither the company nor the author is responsible, directly or indirectly, for any damage or loss caused or alleged to be caused by or in connection with the use of or reliance on any content, goods or services mentioned in this article.

Owen Mayhttps://allstocksnews.com
Owen May is the editor-in-chief of AllStocksNews. He has a master's in economics and you will find him covering various topics.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisment -

Latest News

Trump rails against Covid vaccines for ‘very young people’

“Now we have to get back and the schools have to get open — frankly, we are lucky we...

How will it affect US cases, vaccine efficacy?

As the Delta variant of COVID-19 tore through India last month, there was a lot of concern, but few answers...

Watch the Trailer for Sophie: A Murder in West Cork

Sophie: A Murder in West Cork is a three-part series that examines one of the most famous murders to...

3 Legit Car-Wrap Advertising Gigs, Plus Scams to Avoid

For heavy commuters, ride-share drivers and those looking for passive income opportunities, car wrap advertising is a fairly straightforward...

They’re for ‘Trump over the cops’ : politics

Republicans often blast Democrats for wanting to defund the police. But Democrats have a new rebuttal: The GOP won’t...
- Advertisment -